PubMed

Parental characteristics, somatic fetal growth, and season of birth influence innate and adaptive cord blood cytokine responses.

Gold DR, Bloomberg GR, Cruikshank WW, Visness CM, Schwarz J, Kattan M, O'Connor GT, Wood RA, Burger MS, Wright RJ, Witter F, Lee-Parritz A, Sperling R, Sadovsky Y, Togias A, Gern JE.

J Allergy Clin Immunol. 2009 Nov;124(5):1078-87.PMID: 19895995 [PubMed - in process]Related articles

Differential expression of imprinted genes in normal and IUGR human placentas.

Diplas AI, Lambertini L, Lee MJ, Sperling R, Lee YL, Wetmur J, Chen J.

Epigenetics. 2009 May;4(4):235-40. Epub 2009 May 14.PMID: 19483473 [PubMed - indexed for MEDLINE]Related articles

A sensitive functional assay reveals frequent loss of genomic imprinting in human placenta.

Lambertini L, Diplas AI, Lee MJ, Sperling R, Chen J, Wetmur J.

Epigenetics. 2008 Sep;3(5):261-9. Epub 2008 Sep 7.PMID: 18769151 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.

Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA.

Sex Transm Dis. 2008 Mar;35(3):286-90.PMID: 18157071 [PubMed - indexed for MEDLINE]Related articles

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.

Weir MR, Sperling RS, Reicin A, Gertz BJ.

Am Heart J. 2003 Oct;146(4):591-604. Review.PMID: 14564311 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.

Katz N, Ju WD, Krupa DA, Sperling RS, Bozalis Rodgers D, Gertz BJ, Gimbel J, Coleman S, Fisher C, Nabizadeh S, Borenstein D; Vioxx Chronic Low Back Pain Study Group.

Spine (Phila Pa 1976). 2003 May 1;28(9):851-8; discussion 859.PMID: 12941996 [PubMed - indexed for MEDLINE]Related articles

Blood pressure control and rates of edema following the administration of the cyclooxygenase-2 specific inhibitors celecoxib versus rofecoxib in patients with systemic hypertension and osteoarthritis.

Weaver A, Alderman M, Sperling R.

Am J Cardiol. 2003 May 15;91(10):1291-2. No abstract available. PMID: 12745131 [PubMed - indexed for MEDLINE]Related articles

Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival.

Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, Huang S, Sperling RS, Cunningham B, Gandia J, Maupin R, Zorrilla CD, Jones T, O'Sullivan MJ; Pediatrics AIDS Clinical Trials Group 288 Protocol Team.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):170-81.PMID: 12571527 [PubMed - indexed for MEDLINE]Related articles

A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.

Gertz BJ, Krupa D, Bolognese JA, Sperling RS, Reicin A.

Curr Med Res Opin. 2002;18(2):82-91.PMID: 12017215 [PubMed - indexed for MEDLINE]Related articles

Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone).

Reicin AS, Shapiro D, Sperling RS, Barr E, Yu Q.

Am J Cardiol. 2002 Jan 15;89(2):204-9.PMID: 11792343 [PubMed - indexed for MEDLINE]Related articles